AI Tool Outperforms PD-L1 for Predicting Lung Cancer Immunotherapy Outcomes
Sep 14, 2026
A large international study suggests explainable AI using routinely collected clinical data could improve predictions of which patients with advanced lung cancer will benefit from…
Read More –AACR Report Highlights Rapid Expansion of Molecularly Targeted Cancer Therapies
Sep 16, 2026OpenAI Foundation Gives $125M to Public Data for AI-Driven Health Program
Sep 15, 2026Blood RNA Modification Signature Shows Promise for Early Liver Cancer Detection
Sep 11, 2026Targeted mRNA Nanoparticles Turn Tumor Macrophages Against Cancer
Sep 11, 2026Childhood Chemotherapy Leaves Lasting DNA Damage in Healthy Tissues
Sep 10, 2026Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical Outcomes
Sep 9, 2026AI Repurposes Drugs in Fight Against Antibiotic Resistance
Sep 16, 2026
Smartphone Attachment Screens for Cataracts in Remote Communities
Sep 13, 2026
Childhood Proteome Reveals Precision Prevention Approach for Cardiometabolic Disease
Sep 11, 2026
Mechanism Driving Blood-Clotting Disorder Identified
Sep 11, 2026
Riaan’s Therapeutic Odyssey – Chapter 2: The Researchers
Sep 10, 2026
Nighttime Light Linked with Adverse Heart Changes
Sep 10, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Targetable KRAS G12C Mutation Uncommon in Genitourinary Cancers
Sep 9, 2026Comprehensive genomic profiling of more than 13,000 genitourinary cancers found KRAS G12C mutations in just 0.2% of specimens, suggesting limited utility for routine testing.
Researchers Call for Biologically-Tailored Treatment for Mantle Cell Lymphoma
Sep 9, 2026Researchers propose replacing age-based treatment decisions in mantle cell lymphoma with biomarker-driven risk stratification that could identify patients needing intensified therapy or less intensive treatment.
HLA Gene Variant Linked to Severe Reaction from Anti-Seizure Medication
Sep 8, 2026Testing for HLA-A*32:01 could potentially improve pre-treatment identification of patients at risk for lamotrigine-induced DRESS, a rare but potentially fatal hypersensitivity reaction.
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
